Cambridge & Kendall Square's tenant base is anchored by pharma, biotech, gene therapy, venture capital.
Cambridge & Kendall Square's tenant base is anchored by pharma, biotech, gene therapy, venture capital.
Pharma, biotech, gene therapy, venture capital.
Newcomers to Cambridge & Kendall Square should expect peer-tenant scrutiny: covenant strength, brand fit, and signage standards are watched closely. Lease-up product underwrites by anchor tenant; secondary tenants typically benefit from anchor halo.
| city | Boston |
|---|---|
| submarket | Cambridge & Kendall Square |
| tier | trophy |
| averageRentLocal | $110/sqft/yr |
| cityClassARentUsd | $78/sqft/yr |
| cityVacancyPct | 19.5% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.